HWAM
IRMD icon

Hennion & Walsh Asset Management’s iRadimed IRMD Stock Holding History

Hennion & Walsh Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
+2,269
New +$207K 0.01% 917
2025
Q3 		– Sell
-8,359
Closed -$500K – 957
2025
Q2 		$500K Sell
8,359
-58
-0.7% -$3.18K 0.02% 670
2025
Q1 		$442K Sell
8,417
-189
-2% -$10.6K 0.02% 671
2024
Q4 		$473K Sell
8,606
-101
-1% -$5.32K 0.02% 636
2024
Q3 		$438K Sell
8,707
-60
-0.7% -$2.77K 0.02% 650
2024
Q2 		$385K Sell
8,767
-158
-2% -$6.72K 0.02% 671
2024
Q1 		$393K Buy
8,925
+3,791
+74% +$168K 0.02% 629
2023
Q4 		$244K Buy
+5,134
New +$216K 0.01% 735

Other funds holding IRMD

SI
Shaker Investments Cleveland, Ohio $278M AUM 69.83% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
KPP
Kings Path Partners Sugar Land, Texas $376M AUM 19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Hennion & Walsh Asset Management's IRMD Position: Q2 2026 in Review

Hennion & Walsh Asset Management opened a new position in iRadimed (IRMD) in Q2 2026: 2,269 shares worth $217K. The stake represents 0.01% of the portfolio and ranks #917 among its holdings. This is a return to the name: Hennion & Walsh Asset Management previously reported a position in IRMD as recently as Q2 2025.

Hennion & Walsh Asset Management first reported a position in IRMD in Q4 2023 and has held it in 8 quarters since. The position peaked at $500K in Q2 2025. 18 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Hennion & Walsh Asset Management held 2,269 shares of iRadimed worth $217K as of Q2 2026.
  • iRadimed was a new Hennion & Walsh Asset Management position in Q2 2026.
  • iRadimed made up 0.01% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #917 holding.
  • Hennion & Walsh Asset Management first reported a position in iRadimed in Q4 2023 and has held it in 8 quarters since.
  • Hennion & Walsh Asset Management's iRadimed position peaked at $500K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.